Daphne Haas-Kogan, MD, is chair of the Department of Radiation Oncology at Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Boston Children’s Hospital. She is a Professor of Radiation Oncology at Harvard Medical School.
Dr. Haas-Kogan received her undergraduate degree in Biochemistry and Molecular Biology magna cum laude from Harvard University, was elected to Phi Beta Kappa, received the prestigious Joseph L. Barrett Award for Teaching at Harvard University, and was awarded the Thomas T. Hoopes Prize and summa cum laude for her Senior Honors Thesis. While in medical school, she was an HHMI Medical Fellow in the laboratory of Dr. J. Michael Bishop at UCSF. She received her M.D. from the University of California, San Francisco and was elected to the Alpha Omega Alpha Medical Honor Society. She completed her residency in Radiation Oncology and post-doctoral fellowship in molecular neuro-oncology at UCSF in 1997. She remained at UCSF as a tenure track faculty member with joint appointments in Radiation Oncology and Neurological Surgery, was Vice-Chair for Research since 2003, and Educational Program Director since 2008.
Dr. Haas-Kogan’s laboratory research has focused on characterizing aberrant signaling pathways in gliomas and investigating agents that target these signaling cascades. Dr. Haas-Kogan has been the Principal Investigator on many grants funded by NIH/NCI, philanthropic organizations, and industry collaborations. Dr. Haas-Kogan has been selected as one of the top physicians in the United States by several publications including Best Doctors in America, San Francisco Magazine, and Consumers’ Research Council of America. She has received several teaching awards including the Henry J. Kaiser Award for Excellence in Teaching from UCSF School of Medicine. Dr. Haas-Kogan continues to successfully lead and perform laboratory research, design clinical trials, establish robust collaborations with neuro-pathologists, neuro-oncologists, and neuro-radiologists, and develop a thriving clinical practice in radiation oncology. In 2016, Dr. Haas-Kogan was appointed to the Blue Ribbon Panel of scientific experts, cancer leaders, and patient advocates that will inform the scientific direction and goals at NCI of Vice President Joe Biden’s National Cancer Moonshot Initiative. In 2017, Dr. Haas-Kogan was elected to the Association of American Physicians (AAP). In 2019, Dr. Haas-Kogan was elected to the National Academy of Medicine and was an awarded a Fellowship by the American Society of Radiation Oncology. Most recently, she was awarded the highest mentorship recognition at DFCI as the 2021 recipient of The Edward J. Benz, Jr. Award for Advancing the Careers of Women Faculty.Back to Commercialization Council